Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Cleerly
Cleerly provides AI-powered analysis of 3D coronary CT angiography (CCTA) to enable accurate, non-invasive diagnosis and risk stratification for coronary artery disease. The platform analyzes CT…
Cleerly
Cleerly provides AI-powered analysis of 3D coronary CT angiography (CCTA) to enable accurate, non-invasive diagnosis and risk stratification for coronary artery disease. The platform analyzes CT…
TL;DR
Core offering: AI-driven analysis of coronary CT angiography (CCTA) for quantitative coronary artery disease phenotyping
Mission: Eliminate heart attacks by creating a new standard of care for diagnosis of heart disease
Founded / HQ: Founded 2017; headquartered in Denver, Colorado
Regulatory status: Offers FDA-cleared algorithms
Reported total funding: Approximately $417.8M (company-reported and press figures vary by round)
Company Overview
Problem Domain
Diagnosis and phenotyping of coronary artery disease to prevent heart attacks
Founded
2017
Industry
Medical Equipment Manufacturing
Funding Track Record
43000000
Series B reported at $43M
223000000
Company press materials reported a $223M Series C bringing total to $279M
106000000
Reported as a $106M extension led by Insight Partners with participation from Battery Ventures
Investor Signal
“Institutional and crossover investor interest, including Insight Partners, Battery Ventures, T. Rowe Price, Fidelity, Vensana Capital, and other healthcare investors”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |